Development and evaluation of a pharmacogenomics educational program for pharmacists

American Journal of Pharmaceutical Education

Volumn 77, Issue 1, 2013, Pages

  Formea, Christine M ^a   Nicholson, Wayne T ^a   McCullough, Kristen B ^a   Berg, Kevin D ^b   Berg, Melody L ^a   Cunningham, Julie L ^a   Merten, Julianna A ^a   Ou, Narith N ^a   Stollings, Joanna L ^c  

^a MAYO CLINIC   (United States)

^b St Luke's Hospital   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Continuing education; Genetic testing; Personalized medicine; Pharmacogenomics; Survey

Indexed keywords

ACCREDITATION; AMBULATORY CARE; ARTICLE; ATTITUDE TO HEALTH; CONTINUING EDUCATION; CURRICULUM; EDUCATION; EDUCATIONAL STATUS; EVALUATION; GENETIC SCREENING; HEALTH CARE QUALITY; HOSPITAL PHARMACY; HUMAN; METHODOLOGY; PERSONALIZED MEDICINE; PHARMACIST; PHARMACOGENETICS; PHARMACOGENOMICS; PROGRAM DEVELOPMENT; QUESTIONNAIRE; SURVEY; TEACHING; UNITED STATES; EVALUATION STUDY; PROGRAM EVALUATION;

CONTINUING EDUCATION; GENETIC TESTING; PERSONALIZED MEDICINE; PHARMACOGENOMICS; SURVEY;

ACCREDITATION; AMBULATORY CARE; CURRICULUM; EDUCATION, PHARMACY, CONTINUING; EDUCATIONAL MEASUREMENT; EDUCATIONAL STATUS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIVIDUALIZED MEDICINE; MINNESOTA; PHARMACISTS; PHARMACOGENETICS; PHARMACY SERVICE, HOSPITAL; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUESTIONNAIRES; TEACHING;

EID: 84881654750     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/ajpe77110     Document Type: Article

References (24)

1. Guttmacher AE, Collins FS. Realizing the promise of genomics in biomedical research. JAMA. 2005;294(11):1399-402.
2. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med. 2003;348(6):538-549.
3. Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet. 2001;2:9-39.
4. Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health-Syst Pharm. 2009;66(7):625-637.
5. Gage BF, Lesko LJ. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis. 2008;25(1): 45-51.
6. Holmes DR, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2010;56(4):321-341.
7. U.S. Food and Drug Administration website. Drugs at FDA. FDA approved drug products September 27, 2011 Drug labeling revision. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction5Search.Label_ApprovalHistory#labelinfo Accessed December 26, 2012.
8. Lee KC, Ma JD, Kuo GM. Pharmacogenomics: bridging the gap between science and practice. J Am Pharm Assoc. 2010;50(1):e1-e14.
9. Ellingrod VL, Moline J. Incorporating pharmacogenomics into practice. J Pharm Pract. 2007;20(3):277-282.
10. El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc. 2008;48(2): e21-e32.
11. Brock TP, Valgus JM, Smith SR, Summers KM. Pharmacogenomics: implications and consideration for pharmacists. Pharmacogenomics. 2003;4(3):321-330.
12. Streetman DS. Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years. Ann Pharmacother. 2007;41(12):2038-2041.
13. McCullough KB, Formea CM, Berg KD, et al. Assessment of the pharmacogenomics needs of pharmacists. Am J Pharm Educ. 2011;75 (3): Article 51.
14. Sansgiry SS, Kulkarni AS. The Human Genome Project: assessing confidence in knowledge and training requirements for community pharmacists. Am J Pharm Educ. 2003;67(2): Article 39.
15. Mayo School of Health Sciences, College of Medicine, Mayo Clinic. http://www.mayo.edu/mshs/mcr.html. Accessed November 24, 2011.
16. American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J Am Pharm Assoc. 2011;51(6):e64-e74.
17. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med. 2011;364(12):1144-1153.
18. Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health-Syst Pharm. 2011;68(2):143-150.
19. Gleason BL, Peeters MJ, Resman-Targoff BH, et al. An active-learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ. 2011;75(9): Article 186.
20. Eley JG and Birnie C. Retention of compounding skills among pharmacy students. Am J Pharm Educ. 2006;70(6): Article 132.
21. Mieure KD, Vincent WR, Cox MR, Jones MD. A high-fidelity simulation mannequin to introduce pharmacy students to advanced cardiovascular life support. Am J Pharm Educ. 2010;74(2): Article 22.
22. rd, Wong MT, Bishop AL. Short- and long-term retention of a nursing home education program on metered-dose inhaler technique. Ann Pharmacother. 1992;26(7-8):980-984.
23. Fjortoft NF. Learning outcomes and behavioral changes with a pharmacy continuing professional education program. Am J Pharm Educ. 2006;70(2): Article 24.
24. Kopacek KB, Dopp AL, Dopp JM, Vardeny O, Sims JJ. Pharmacy students' retention of knowledge and skills following training in automated external defibrillator use. Am J Pharm Educ. 2010;74(6): Article 109.